AKT1 and pancreatic neoplasm: We demonstrated that Evr exhibited anti-cancer properties by inhibiting the activation of the PI3K/AKT/mTOR pathway to regulate glucose metabolism, tube formation, cell migration, and apoptosis in pancreatic cancer cells.